Side Effects and Safety Considerations The most common side effects in trials were gastrointestinal including nausea, vomiting, and diarrhoea and were dose-dependent
Research has already suggested that the current lifestyle, including food habits and stress, has resulted in obesity becoming the current epidemic that it is
These findings also confirm the chronicity of obesity and suggest ongoing treatment is required to maintain improvements in weight and health." A new European consortium known as Sophia (Stratification of Obese Phenotypes to Optimize Future Obesity Therapy), led by scientists at University College Dublin, is now attempting to investigate this in more detail
placebo users
Provides simple carbs for energy when protein is impossible
Treatment is customized by licensed providers based on your health history, goals, and lab results Our compounded formulation offers a more accessible option for GLP-1 therapy while maintaining provider oversight and quality pharmacy sourcing
